Real World Data on the Use of Ruxolitinib and Treatment Selection in chronic GvHD
August 9th 2023Discussion centered around real-world data following the approval of ruxolitinib as a treatment option for patients with chronic GvHD as well as discussing treatment selection for patients with chronic GvHD, with special consideration for treatment sequencing.
Read More